What is PharmGKB?

PharmGKB is an NIH-funded resource that provides information about how human genetic variation affects response to medications. PharmGKB collects, curates and disseminates knowledge about clinically actionable gene-drug associations and genotype-phenotype relationships. When using PharmGKB, you will see different types of information. These are detailed in the sections below.

Curated Pathways

Curated pathways are evidence-based diagrams of how a medication is metabolized in your body, how a medication works in the body, or both. Pathways diagrams are also accompanied by a written description.

PharmGKB pathways focus on either the pharmacokinetics(opens in new window) or pharmacodynamics(opens in new window) of a drug(opens in new window), and depict the key candidate pharmacogenes that code for the proteins(opens in new window) involved in these processes. Most pathways are interactive, allowing users to access more information by clicking on the objects in the pathway. In progress pathways provide the preliminary underlying reactions, genes, metabolites and evidence in a machine readable format but have not yet been developed for publication in a peer-reviewed journal.

Connections on a pathway are supported by literature evidence, which can be viewed on the pathway page. Pathways are typically created in collaboration with experts in the field. They are available for download in multiple formats, including as a PDF file. In addition to being provided on the PharmGKB website, pathways are normally published in the journal Pharmacogenetics and Genomics.